Astellas Pharma, Inc. (ALPMF) - OTCPK - Current
  • Clinically Sound Investor | Send Message 21 Jan 2015

    Astellas' Isavuconazonium Should Pass Ad Comm Meeting For Two Indications $ALPMF http://seekingalpha.com/a/1osbw
    Reply
      Company Description
      Currently, there's no company description for ALPMF.
      Sector: Healthcare
      Industry: Drug Related Products
      Country: Japan